This announcement is a separate document:
山東新華製藥股份：海外監管公告-關於獲得《藥品補充申請批准通知書》等相關情況的公告
SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.